These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 33853705)

  • 1. Association Analysis of Hyperlipidemia with the 28-Day All-Cause Mortality of COVID-19 in Hospitalized Patients.
    Wu B; Zhou JH; Wang WX; Yang HL; Xia M; Zhang BH; She ZG; Li HL
    Chin Med Sci J; 2021 Mar; 36(1):17-26. PubMed ID: 33853705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico.
    Woolcott OO; Castilla-Bancayán JP
    Sci Rep; 2021 Apr; 11(1):8386. PubMed ID: 33863997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Leucocyte to High-Density Lipoprotein-Cholesterol Ratios in COVID-19 Patients and the Diabetes Subgroup.
    Wang Y; Zhang J; Li H; Kong W; Zheng J; Li Y; Wei Q; Li Q; Yang L; Xu Y; Li L; Wang H; Sun H; Xia W; Liu G; Zhong X; Qiu K; Wang H; Liu H; Song X; Xiong S; Liu Y; Cui Z; Chen L; Zeng T
    Front Endocrinol (Lausanne); 2021; 12():727419. PubMed ID: 34589058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes.
    Chen X; Chen Y; Wu C; Wei M; Xu J; Chao YC; Song J; Hou D; Zhang Y; Du C; Li X; Song Y
    BMJ Open Diabetes Res Care; 2020 Nov; 8(2):. PubMed ID: 33214191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
    J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysis.
    Yousufuddin M; Takahashi PY; Major B; Ahmmad E; Al-Zubi H; Peters J; Doyle T; Jensen K; Al Ward RY; Sharma U; Seshadri A; Wang Z; Simha V; Murad MH
    BMJ Open; 2019 Dec; 9(12):e028638. PubMed ID: 31843818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients.
    Toth PP; Philip S; Hull M; Granowitz C
    Mayo Clin Proc; 2019 Sep; 94(9):1670-1680. PubMed ID: 31405751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.
    Albers JJ; Slee A; Fleg JL; O'Brien KD; Marcovina SM
    Atherosclerosis; 2016 Aug; 251():454-459. PubMed ID: 27320173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
    Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Cardio-Metabolic Disease Increases the Risk of Worse Outcomes Among Hospitalized Patients With COVID-19: A Multicenter, Retrospective, and Real-World Study.
    Chen Q; Wang L; Li C; Hu W; Fan Y; Chen Z; Wu L; Lu Z; Ye J; Chen S; Tong J; Ruan L; Mei J; Lu H
    J Am Heart Assoc; 2021 Jun; 10(12):e018451. PubMed ID: 34096317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: a propensity score-matching analysis.
    Yang Q; Zhou Y; Wang X; Gao S; Xiao Y; Zhang W; Hu Y; Wang Y
    Respir Res; 2020 Jul; 21(1):172. PubMed ID: 32631365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes.
    Fan D; Li L; Li Z; Zhang Y; Ma X; Wu L; Qin G
    Lipids Health Dis; 2018 May; 17(1):102. PubMed ID: 29739462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia.
    Keating GM; Ormrod D
    Drugs; 2002; 62(13):1909-44. PubMed ID: 12215067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study.
    Jiang N; Chen Z; Liu L; Yin X; Yang H; Tan X; Wang J; Li H; Tian M; Lu Z; Xiong N; Gong Y
    Diabetes Res Clin Pract; 2021 Mar; 173():108619. PubMed ID: 33310173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality.
    Cusacovich I; Aparisi Á; Marcos M; Ybarra-Falcón C; Iglesias-Echevarria C; Lopez-Veloso M; Barraza-Vengoechea J; Dueñas C; Juarros Martínez SA; Rodríguez-Alonso B; Martín-Oterino JÁ; Montero-Baladia M; Moralejo L; Andaluz-Ojeda D; Gonzalez-Fuentes R
    Mediators Inflamm; 2021; 2021():6637227. PubMed ID: 33776574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
    Ye X; Qian C; Liu J; St Peter WL
    Pharmacotherapy; 2013 Oct; 33(10):1062-70. PubMed ID: 23798059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
    Trifirò G; Massari M; Da Cas R; Menniti Ippolito F; Sultana J; Crisafulli S; Giorgi Rossi P; Marino M; Zorzi M; Bovo E; Leoni O; Ludergnani M; Spila Alegiani S;
    Drug Saf; 2020 Dec; 43(12):1297-1308. PubMed ID: 32852721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.